Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN)

  • Takashi Muramatsu
  • , Shinichiro Masuda
  • , Nozomi Kotoku
  • , Ken Kozuma
  • , Hideyuki Kawashima
  • , Yuki Ishibashi
  • , Gaku Nakazawa
  • , Kuniaki Takahashi
  • , Takayuki Okamura
  • , Yosuke Miyazaki
  • , Hiroki Tateishi
  • , Masato Nakamura
  • , Norihiro Kogame
  • , Taku Asano
  • , Shimpei Nakatani
  • , Yoshihiro Morino
  • , Yuki Katagiri
  • , Kai Ninomiya
  • , Shigetaka Kageyama
  • , Hiroshi Takahashi
    • Scot Garg, Shengxian Tu, Kengo Tanabe, Yukio Ozaki, Patrick W. Serruys, Yoshinobu Onuma

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Prasugrel Monotherapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Platinum-Chromium Everolimus Eluting Stent for Japanese Patients With Chronic Coronary Syndrome (ASET-JAPAN)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science